Clalis capsules recalled for undeclared sildenafil ingredient
Fabscout Entertainment, Inc. is recalling Clalis capsules because FDA analysis found they contain sildenafil, an undeclared active pharmaceutical ingredient.
- Product
- Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)
- Category
- Drug
- Distribution
- Distributed nationwide